
浏览全部资源
扫码关注微信
纸质出版:2010
移动端阅览
冯婷,刘霞,黄幼田,杨红艳,董子明.曲古菌素A上调食管癌CAR的表达及增强溶瘤腺病毒转染效率的体外研究[J].陆军军医大学学报(原第三军医大学学报),2010,32(22):2404-2408.
Feng Ting,Liu Xia,Huang Youtian,Yang Hongyan,Dong Ziming.Trichostatin A enhances transfection efficiency of oncolytic adenovirus in vitro through up-regulating CAR in human esophageal cancer cell line EC9706[J].J Amry Med Univ (J Third Mil Med Univ),2010,32(22):2404-2408.
冯婷,刘霞,黄幼田,杨红艳,董子明.曲古菌素A上调食管癌CAR的表达及增强溶瘤腺病毒转染效率的体外研究[J].陆军军医大学学报(原第三军医大学学报),2010,32(22):2404-2408. DOI:
Feng Ting,Liu Xia,Huang Youtian,Yang Hongyan,Dong Ziming.Trichostatin A enhances transfection efficiency of oncolytic adenovirus in vitro through up-regulating CAR in human esophageal cancer cell line EC9706[J].J Amry Med Univ (J Third Mil Med Univ),2010,32(22):2404-2408. DOI:
目的 通过观察组氨酸去乙酰化酶(histone deacetylase,HDAC)抑制剂曲古菌素(trichostatin A
TSA)对食管癌细胞株EC9706膜表面柯萨奇-腺病毒受体(Coxsackie and adenovirus receptor,CAR)表达水平的影响,观察TSA能否通过上调食管癌EC9706 CAR表达而增强其对腺病毒基因转染效率。 方法 采用免疫细胞组织化学、RT-PCR、Western blot检测食管癌EC9706细胞CAR的表达情况,再用上述方法检测TSA作用EC9706细胞后,CAR mRNA和CAR蛋白表达的改变;同时采用流式细胞术测定病毒转染效率,MTT实验评价腺病毒携带的胸苷激酶(Ad-TK)的体外抗瘤效应。 结果 0.5 μmol/L TSA处理EC9706细胞12、24、48 h后,CAR mRNA和蛋白表达量[分别为(0.44±0.01)、(0.37±0.02)
(0.66±0.04)、(0.58±0.01)
(0.77±0.05)、(0.70±0.03)]与未加TSA处理组[(0.27±0.02)、(0.22±0.03)]相比,CAR mRNA和蛋白表达水平显著提高(P0.05,P0.01),呈现出时间依赖关系。流式细胞仪分析AdGFP转染后GFP的表达发现,未加TSA处理细胞转染效率为(1.35±0.11)%,0.5 μmol/L TSA作用12、24 h 和48 h后,细胞转染效率分别为(2.58±0.17)%、(4.96±0.14)%、(6.36±0.15)%。MTT检测Ad-TK介导的体外杀伤作用结果显示,0.5 μmol/L TSA作用48 h比未加TSA增强8倍。 结论 TSA通过上调CAR表达量从而增强腺病毒对食管癌细胞的腺病毒基因转染效率。
Objective To explore the effect of histone deacetylase (HDAC) inhibitor
trichostatin A (TSA)
on the expression of Coxsackie and adenovirus receptor (CAR) in esophageal cancer cell line EC9706. Methods Immunocytochemistry
RT-PCR and Western blotting were used to detect the expression of CAR in EC9706 cells
and its mRNA and protein expressions after the treatment of 0.5 mol/L TSA for 12
24 and 48 h were also studied. Transfection efficiency of virus Ad-GFP in the EC9706 cells with or without 0.5 mol/L TSA treatment was determined by flow cytometry. Anti-tumor effect of adenovirus carrying thymidine kinase (Ad-TK) was evaluated by MTT assay. Results After 0.5 μmol/L TSA treatment for 12
24 and 48 h
CAR mRNA and protein expression were 0.44±0.01 and 0.37±0.02
0.66±0.04 and 0.58±0.01
and 0.77±0.05 and 0.70±0.03 respectively. Compared to those of control group (0.27±0.02 and 0.22±0.03)
the CAR mRNA and protein expressions were significantly increased in EC9706 cells after TSA treatment (P0.05
0.01)
and the expressions showed a time-dependent manner. Flow cytometry indicated that the transfection efficiency was (1.35±0.11)% in the EC9706 cells
but was (2.58±0.17)%
(4.96±0.14)%
and (6.36±0.15)% respectively in the cells after 0.5 μmol/L TSA treatment for 12
24 and 48 h. MTT results showed that the Ad-TK-mediated cytotoxicity in the cells with 0.5 μmol/L TSA treatment for 48 h was eight times higher than in the cells untreated. Conclusion TSA can increase gene transfer efficiency of adenovirus into cancer cells by upregulating CAR.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621